Omega Therapeutics OMGA Stock
Omega Therapeutics Price Chart
Omega Therapeutics OMGA Financial and Trading Overview
| Omega Therapeutics stock price | 2.68 USD |
| Previous Close | 8.24 USD |
| Open | 8.24 USD |
| Bid | 0 USD x 1100 |
| Ask | 0 USD x 800 |
| Day's Range | 7.45 - 8.35 USD |
| 52 Week Range | 2.52 - 11.98 USD |
| Volume | 190.11K USD |
| Avg. Volume | 104.34K USD |
| Market Cap | 437.43M USD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.8 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 11.71 USD |
OMGA Valuation Measures
| Enterprise Value | 338.84M USD |
| Trailing P/E | N/A |
| Forward P/E | -3.8970587 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 188.46774 |
| Price/Book (mrq) | 3.5570471 |
| Enterprise Value/Revenue | 145.99 |
| Enterprise Value/EBITDA | -3.165 |
Trading Information
Omega Therapeutics Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | 189.09% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 11.98 USD |
| 52 Week Low | 2.52 USD |
| 50-Day Moving Average | 8.14 USD |
| 200-Day Moving Average | 6.68 USD |
OMGA Share Statistics
| Avg. Volume (3 month) | 104.34K USD |
| Avg. Daily Volume (10-Days) | 109.47K USD |
| Shares Outstanding | 55.02M |
| Float | 21.16M |
| Short Ratio | 13.53 |
| % Held by Insiders | 3.43% |
| % Held by Institutions | 85.47% |
| Shares Short | 1.05M |
| Short % of Float | 5.42% |
| Short % of Shares Outstanding | 1.90% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -4680.095% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -36.34% |
| Return on Equity (ttm) | -70.84% |
Income Statement
| Revenue (ttm) | 2.32M USD |
| Revenue Per Share (ttm) | 0.05 USD |
| Quarterly Revenue Growth (yoy) | 92.50% |
| Gross Profit (ttm) | -74023000 USD |
| EBITDA | -107066000 USD |
| Net Income Avi to Common (ttm) | -107816000 USD |
| Diluted EPS (ttm) | -2.31 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 136.79M USD |
| Total Cash Per Share (mrq) | 2.49 USD |
| Total Debt (mrq) | 22.24M USD |
| Total Debt/Equity (mrq) | 18.08 USD |
| Current Ratio (mrq) | 8.222 |
| Book Value Per Share (mrq) | 2.235 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -103276000 USD |
| Levered Free Cash Flow (ttm) | -63401752 USD |
Profile of Omega Therapeutics
| Country | United States |
| State | MA |
| City | Cambridge |
| Address | 20 Acorn Park Drive |
| ZIP | 02140 |
| Phone | 617 949 4360 |
| Website | https://omegatherapeutics.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 116 |
Omega Therapeutics, Inc. operates as a clinical-stage biotechnology company. The company's OMEGA platform enables control of fundamental epigenetic processes to correct the root cause of disease by restoring aberrant gene expression to a range without altering native nucleic acid sequences. It also develops OTX-2002 for hepatocellular carcinoma; OTX-2101 for non-small cell lung cancer; omega epigenomic controllers (OEC) for inflammatory lung diseases, such as neutrophilic asthma, acute respiratory distress syndrome, dermatological, oncology, and rheumatological indications; OEC candidates for idiopathic pulmonary fibrosis; liver regeneration medicines; and OEC candidates for patients with diabetes and other conditions to treat corneal epithelial injury. In addition, the company develops OEC candidates for the treatment of alopecia, a disorder characterized by patches of non-scarring hair loss affecting the scalp and body. Omega Therapeutics, Inc. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.
Q&A For Omega Therapeutics Stock
What is a current OMGA stock price?
Omega Therapeutics OMGA stock price today per share is 2.68 USD.
How to purchase Omega Therapeutics stock?
You can buy OMGA shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Omega Therapeutics?
The stock symbol or ticker of Omega Therapeutics is OMGA.
Which industry does the Omega Therapeutics company belong to?
The Omega Therapeutics industry is Biotechnology.
How many shares does Omega Therapeutics have in circulation?
The max supply of Omega Therapeutics shares is 55.15M.
What is Omega Therapeutics Price to Earnings Ratio (PE Ratio)?
Omega Therapeutics PE Ratio is now.
What was Omega Therapeutics earnings per share over the trailing 12 months (TTM)?
Omega Therapeutics EPS is -1.8 USD over the trailing 12 months.
Which sector does the Omega Therapeutics company belong to?
The Omega Therapeutics sector is Healthcare.
Omega Therapeutics OMGA included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| Stlmt ID NASDAQ Biotechnology NBX | 4604.4 USD — |
-2.98
|
— — | 4555.41 USD — | 4917.8 USD — | — - | — — |
| NASDAQ Global Select Market Com NQGS | 7876.03 USD — |
-1.61
|
— — | 7852.08 USD — | 7955.84 USD — | — - | — — |
| NASDAQ Biotechnology NBI | 4195.13 USD — |
-2.14
|
— — | 4174.1 USD — | 4266.29 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
- {{ link.label }} {{link}}